Medicine and Dentistry
Atopic Dermatitis
100%
Population
100%
Symptom
82%
Cohort Effect
75%
Mastocytosis
70%
Systemic Mastocytosis
69%
Urticaria Pigmentosa
65%
Mastocytoma
62%
Hydroxychloroquine
50%
Lichen Planus
50%
Morphology
50%
Sarcoma
50%
Cladribine
50%
Wasp Venom
50%
Vulva
50%
Neoplasm
50%
Syringoma
50%
Systemic Therapy
50%
Immunotherapy
50%
Neurosyphilis
50%
Papule
50%
COVID-19
50%
Mast Cell
45%
Syphilis
35%
Infection
32%
Human Immunodeficiency Virus
32%
Public Health
29%
Clinician
25%
General Practitioner
25%
Diagnosis
25%
Condom Use
25%
Outpatient
25%
Disease Duration
25%
Prevalence
21%
Tryptase
20%
Histopathology
20%
Sweat Gland Tumor
16%
Cheek
16%
Eosinophil
16%
Lower Eyelid
16%
Side Effect
16%
Chronic Stress
12%
Skin Tumor
12%
Bone Marrow Biopsy
12%
Mitosis Rate
12%
Topical Treatment
12%
Dermatitis
12%
Disease Course
12%
Symptomatic Treatment
12%
Rare Disease
12%
Keyphrases
Atopic Dermatitis
100%
Systemic Treatment
50%
Erosive Lichen Planus
50%
Hydroxychloroquine
50%
Cutaneous Mast Cell Tumor
50%
Vulva
50%
Cladribine
50%
Rush Immunotherapy
50%
Loneliness
50%
Psychiatric Disorders
50%
Disease Duration
50%
Cutaneous Mastocytosis
50%
Dutch
50%
COVID-19 Related
50%
Lifestyle Factors
50%
Epidemiology
50%
Syringoma
37%
Moderate-to-severe Atopic Dermatitis
33%
Extragenital
25%
Indicator Conditions
25%
Mastocytosis
25%
Antihistamines
25%
Maculopapular
25%
Mast Cells
25%
Spontaneous Regression
25%
Rare Diseases
25%
Maculopapular Cutaneous Mastocytosis
25%
Pruritus
25%
Puberty
25%
Mastocytoma
25%
Chronic Urticaria
25%
Diffuse Cutaneous Mastocytosis
25%
Large Lesions
25%
Small Lesions
25%
Asymptomatic Neurosyphilis
20%
COVID-19
16%
Moderate to Severe
13%
Severely Affected
13%
Netherlands
13%
Eccrine Sweat Gland Tumor
12%
Luminal Differentiation
12%
Remission
12%
Disease Course
12%
Everyday Practices
12%
Topical Treatment
12%
Trephine Biopsy
12%
Inflammatory Skin Diseases
12%
Aggressive Systemic Mastocytosis
10%
Bone Marrow Suppression
10%
Mast Cell Infiltration
10%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Mastocytosis
69%
Mastocytosis
58%
Wasp Venom
50%
Cladribine
50%
Immunotherapy
50%
Atopic Dermatitis
50%
Baricitinib
50%
Adverse Event
21%
Symptom
16%
Side Effect
16%
Urticaria Pigmentosa
15%
Dupilumab
14%
Histamine
8%
Bone Marrow Suppression
8%
Epileptic Absence
8%
Remission
8%
Hematologic Malignancy
8%
Physical Disease by Body Function
8%
Tryptase
8%
Prospective Study
7%
Nausea
7%
Herpes Simplex
7%
Eczema
7%
Urinary Tract Infection
7%
Clinical Trial
7%
Janus Kinase 1
7%
Pruritus
7%
